657P Prospective validation of the T cell engager (TCE) score in patients treated with bispecific CD3 TCE antibodies in phase I clinical trials
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.723
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
0
Citations
0
h-index
0
i10-index
K. Ouali is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers.
Click to start Chat